Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 10, 2023

BUY
$118.38 - $210.04 $146,199 - $259,399
1,235 New
1,235 $0
Q1 2022

Apr 14, 2022

SELL
$126.46 - $235.05 $17,957 - $33,377
-142 Reduced 8.36%
1,556 $268,000
Q2 2021

Jul 16, 2021

SELL
$129.91 - $234.98 $3,767 - $6,814
-29 Reduced 1.68%
1,698 $399,000
Q1 2021

Apr 20, 2021

BUY
$109.18 - $185.98 $188,553 - $321,187
1,727 New
1,727 $226,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mc Guire Investment Group, LLC Portfolio

Follow Mc Guire Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Guire Investment Group, LLC with notifications on news.